Auna S.A. announced the completion of a $765 million debt refinancing, extending the maturities of its outstanding debt and reducing its overall interest expense. The transaction, executed by Auna and its health‑plan arm Oncosalud S.A.C., is designed to improve cash‑flow generation and provide greater financial flexibility for future investments.
By lowering its cost of capital, the refinancing supports Auna’s ongoing deleveraging plan and enhances its balance‑sheet resilience across its operations in Mexico, Peru, and Colombia. The additional liquidity will enable the company to accelerate the deployment of its vertically integrated “AunaWay” model, including expansion of high‑complexity oncology services.
The move aligns with Auna’s commitment to reduce net debt to EBITDA to 3×, a target that will be easier to achieve with the reduced interest burden. Overall, the refinancing positions the company to pursue strategic growth initiatives while maintaining a stronger capital structure.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.